Supports K@W’s Innovation Content Pfizer Inc. raked in more than $12.4 billion in revenue in both 2007 and 2008 from just one drug, Lipitor. The cholesterol-lowering mega-blockbuster accounted for more than a quarter of the pharmaceutical giant’s total revenue in those years.
But those golden days couldn’t last.
{iframe}http://knowledge.wharton.upenn.edu/article/how-pfizers-allergan-buy-will-boost-its-drug-pipeline/?utm_source=kw_newsletter&utm_medium=email&utm_campaign=2015-12-02{/iframe}